Multidrug-resistant Tuberculosis (MDR TB)

Aswita Damayanti(1*), Alfi Raudatil Jannah(2)

(1) Puskesmas Kaligesing Purworejo; Purworejo; Jawa Tengah; Indonesia
(2) Department of Family and Community Medicine; Faculty of Medicine, Public Health and Nursing; Universitas Gadjah Mada; Indonesia
(*) Corresponding Author


...................... The patient lived with her husband, her three children, and a very old mother-in-law. The patient was the first child of 2 siblings with a history of spontaneous birth and was assisted by a birth attendant with cry spontaneously. Her mother-in-law had the same history of the disease, i.e., the first category of pulmonary TB. Her mother-in-law was treated at the primary health care facility for six months and was declared cured by the primary health care facility ten years ago. Her sister-in-law also suffered from the third category of pulmonary TB and did not regularly take the medication, and she died two years ago. The patients have a history of miscarriage once, which was during her fourth pregnancy. Her mother and father were Javanese. The patient's husband worked as a laborer on a coconut farm. So, the income was uncertain every day. The patient came from the lower socio-economic class, so the patient had health insurance for low-income people or JAMKESMAS (Health Coverage). The patient's social relationship with the community was not good because the neighborhood marginally ostracized the patient's family due to her family history which suffered from pulmonary tuberculosis........................


Multidrug-resistant Tuberculosis; MDR TB; Health Coverage; PMO; DOT-TB

Full Text:



1. Sun Y, Harley D, Vally H, Sleigh A. Comparison of characteristics and mortality in multidrug-resistant (MDR) and non-MDR tuberculosis patients in China. BMC Public Health. 2015;15(1).

2. Ministry of Health, Republic of Indonesia. Technical guidelines for integrated management of control of tuberculosis drug resistance. Jakarta: Ministry of Health, Republic of Indonesia. 2013

3. Seung K, Keshavjee S, Rich M. Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harbor Perspectives in Medicine. 2015;5(9):a017863.

4. Marahatta S. Multi-drug resistant tuberculosis burden and risk factors: An update. Kathmandu University Medical Journal. 2010;8(12):116-125.

5. Sharma S, Mohan A. Multidrug-Resistant Tuberculosis. Indian Journal of Medical Research. 2004;120:354-376.

6. Rich M, Jaramillo E. Companion Handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization. 2014.

7. Jaramillo E, Blanc L. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization. 2011.

8. Surya A, Basri C, Kamso S. National tuberculosis control guidelines. Jakarta: Ministry of Health, Republic of Indonesia. 2011.

9. Husain F. Guidelines for prevention and control of tuberculosis infection in hospitals. Jakarta: Department of Health of the Republic of Indonesia. 2010.

10. Sairenji T, Wilson SA, D'Amico F, Peterson LE. Training family medicine residents to perform home visits: a CERA survey. Journal of Graduate Medical Education. 2017 Feb;9(1):90-6.

11. Brian K. Unwin, Anthony F. Jerant. The home visit. American Family Physician. 1999;60(5):1481-1488.

12. Törün T, Güngör G, Ozmen I, Bölükbaşi Y, Maden E, Biçakçi B, et al. Side effects associated with the treatment of multidrug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease. 2005;9(12).

13. Tag El Din M, El Maraghy A, Abdel Hay A. Adverse reactions among patients being treated for multi-drug resistant tuberculosis at Abbassia Chest Hospital. Egyptian Journal of Chest Diseases and Tuberculosis. 2015;64(4):939-952.

14. Chung-Delgado K, Guillen-Bravo S, Revilla-Montag A, Bernabe-Ortiz A. Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors. PloS One. 2015 Mar 19;10(3):e0119332.


Article Metrics

Abstract views : 1798 | views : 4473


  • There are currently no refbacks.

Copyright (c) 2018 Aswita Damayanti, Alfi Raudatil Jannah

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

View My Stats